600479 千金藥業
按盤價 
9.940 -0.290 (-2.835%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.914 | 13.911 | 13.853 | 13.677 | 13.370 |
| 總資產報酬率 ROA (%) | 0.981 | 6.882 | 6.958 | 7.288 | 7.389 |
| 投入資產回報率 ROIC (%) | 1.533 | 10.714 | 10.758 | 10.912 | 10.296 | 邊際利潤分析 |
| 銷售毛利率 (%) | 45.740 | 46.117 | 43.127 | 44.533 | 44.009 |
| 營業利潤率 (%) | 7.123 | 12.161 | 11.034 | 11.906 | 11.695 |
| 息稅前利潤/營業總收入 (%) | 7.017 | 10.925 | 10.990 | 11.663 | 10.949 |
| 淨利潤/營業總收入 (%) | 6.096 | 10.399 | 9.615 | 10.228 | 9.931 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 111.329 | 96.058 | 92.331 | 83.481 | 87.740 |
| 價值變動淨收益/利潤總額(%) | -2.425 | 3.447 | 4.408 | 6.094 | 5.692 |
| 營業外收支淨額/利潤總額(%) | 0.336 | -0.330 | 0.351 | -0.648 | 0.096 | 償債能力分析 |
| 流動比率 (X) | 2.303 | 2.279 | 2.070 | 2.375 | 2.315 |
| 速動比率 (X) | 1.948 | 1.933 | 1.717 | 1.929 | 1.954 |
| 資產負債率 (%) | 35.085 | 35.283 | 39.217 | 33.503 | 34.685 |
| 帶息債務/全部投入資本 (%) | 15.701 | 17.379 | 21.608 | 14.713 | -- |
| 股東權益/帶息債務 (%) | 515.131 | 456.082 | 345.886 | 549.891 | 418.089 |
| 股東權益/負債合計 (%) | 146.649 | 144.817 | 121.975 | 158.081 | 154.546 |
| 利息保障倍數 (X) | -53.735 | -9.135 | -132.889 | -69.843 | -14.467 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 28.537 | 23.971 | 21.422 | 22.892 | 0.000 |
| 存貨周轉天數 (天) | 89.902 | 99.653 | 90.145 | 92.520 | 0.000 |
| 備註： | 即時報價更新時間為 04/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
